Lionex GmbH
Germany DE-MF-000038504 Last updated 21 Oct 2026
- Devices
- 8
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
LIODetect® Troponin I Rapid Test Ref Troponin I_10_EN
LIODetect® D-Dimer Rapid Test Ref D-Dimer_10_EN
LIODetect® CRP 10-30 Rapid Test Ref CRP 10-30_10_EN
LIODetect® CRP 10-60 Rapid Test Ref CRP 10-60_10_EN
LIOFeron® TB/LTBI Ref LIOFeron 02_44
LIOFeron® TB/LTBI Ref LIOFeron 01_22
LIOFeron® TB/LTBI Ref LIOFeron 02_22
LIODetect® TB-ST Ref 3010_EN
About
Since its founding in 1999, Lionex has been dedicated to the cause of tuberculosis. Over nearly three decades, the company has built deep expertise in mycobacterial research and diagnostics. We offer a comprehensive portfolio including IGRA tests, ELISA kits, rapid lateral flow assays, and highly purified antigens. Our solutions support early detection, research, and public health efforts against TB and related diseases globally.
What Lionex GmbH makes
Lionex GmbH manufactures rapid diagnostic tests for infectious diseases, including lateral flow assays for troponin I, D-dimer, and C-reactive protein (CRP) in varying sensitivity ranges. The company also produces diagnostic tools for tuberculosis, such as the LIOFeron® IGRA test for latent TB infection and the LIODetect® TB-ST assay for detecting *Mycobacterium tuberculosis* antigens.
These products fall under In Vitro Diagnostic (IVD) classifications, with some classified as Class C and others under IVD General. The company’s devices are registered in the EU’s eudamed database. Lionex GmbH is headquartered in Germany.
Information
- Country
- Germany
- Address
- 196, Salzdahlumer Strasse, BRAUNSCHWEIG, Germany
- Website
- www.lionex.de
- [email protected]
- Phone
- +495312601266
- PRRC contact
- Mahavir Dr. Singh
- EUDAMED SRN
- DE-MF-000038504